Muscarinic receptor antagonists in the treatment of overactive bladder
- 1 May 2000
- Vol. 55 (5) , 33-46
- https://doi.org/10.1016/s0090-4295(99)00492-6
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- TOLTERODINE IS EFFECTIVE AND WELL TOLERATED DURING LONG-TERM USE IN PATIENTS WITH OVERACTIVE BLADDERJournal of Urology, 1999
- Treatment of detrusor instability with oxybutynin rectal suppositoriesInternational Urogynecology Journal, 1998
- Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivoBritish Journal of Pharmacology, 1997
- Tolterodine-a new bladder selective muscarinic receptor antagonist: Preclinical pharmacological and clinical dataLife Sciences, 1997
- Anticholinergic medication for the unstable bladder: Prospective trials of imipramine/propantheline versus penthienate and oxybutynin versus penthienateInternational Urogynecology Journal, 1996
- Intravesical oxybutynin for spinal cord injury patientsSpinal Cord, 1996
- A Review of the Quality-of-Life Aspects of Urinary Urge IncontinencePharmacoEconomics, 1996
- Pre-clinical and clinical pharmacology of selective muscarinic M3 receptor antagonistsLife Sciences, 1995
- Evidence for inhibitory nicotinic and facilitatory muscarinic receptors in cholinergic nerve terminals of the rat urinary bladderJournal of the Autonomic Nervous System, 1992
- Identification and characterization of muscarinic cholinergic receptors in the human urinary bladder and parotid glandJournal of the Autonomic Nervous System, 1987